Feasibility of Tomotherapy-Based Image-Guided Radiotherapy for Locally Advanced Oropharyngeal Cancer

PLoS ONE

Volumn 8, Issue 3, 2013, Pages

  Nguyen, Nam P ^a   Ceizyk, Misty ^a   Vos, Paul ^b   Betz, Michael ^c   Chi, Alexander ^d   Almeida, Fabio ^e   Davis, Rick ^a   Slane, Benjamin ^a   Gelumbauskas, Steven ^a   Smith Raymond, Lexie ^a   Abraham, Dave ^a   Stevie, Michelle ^a   Jang, Siyoung ^a   Vinh Hung, Vincent ^f  

^a UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

^b EAST CAROLINA UNIVERSITY   (United States)

^c Hirslanden Radiation Oncology Institute   (Switzerland)

^d WEST VIRGINIA UNIVERSITY   (United States)

^e Southwest PET/CT Institute   (United States)

^f GENEVA UNIVERSITY HOSPITALS   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CARBOPLATIN; CETUXIMAB; CISPLATIN; CONTRAST MEDIUM; DOCETAXEL; FLUOROURACIL; ANTINEOPLASTIC AGENT;

ADULT; ADVANCED CANCER; AGED; AREA UNDER THE CURVE; ARTICLE; CANCER CONTROL; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; DISTANT METASTASIS; FEASIBILITY STUDY; FEMALE; GASTROINTESTINAL TOXICITY; HEMATURIA; HUMAN; IMAGE GUIDED RADIOTHERAPY; MALE; MOUTH HYGIENE; MUCOSA INFLAMMATION; MULTIPLE CYCLE TREATMENT; NAUSEA AND VOMITING; ORAL MUCOSAL DISEASE; OROPHARYNX CANCER; RADIATION DOSE; RADIATION DOSE DISTRIBUTION; RADIATION DOSE FRACTIONATION; RETROSPECTIVE STUDY; SQUAMOUS CELL CARCINOMA; SURVIVAL TIME; TOMOTHERAPY; TUMOR LOCALIZATION; MIDDLE AGED; OROPHARYNGEAL NEOPLASMS; PROCEDURES; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS; CISPLATIN; FEMALE; HUMANS; MALE; MIDDLE AGED; OROPHARYNGEAL NEOPLASMS; RADIOTHERAPY, IMAGE-GUIDED; RETROSPECTIVE STUDIES;

EID: 84875481673     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0060268     Document Type: Article

References (27)

1. Shiboski CH, Schmidt BL, Jordan RC, (2005) Tongue and tonsil carcinoma. Increasing trends in the U.S. population ages 20-44 years. Cancer 103: 1843-1849.
2. Nguyen NP, Chi A, Nguyen LM, Ly BH, Karlsson U, et al. (2010) Human papillomavirus-associated oropharyngeal cancer: a new clinical entity. Q J Med 103: 229-236.
3. Jemal A, Siegel R, Ward E, Hao Y, Xu J, et al. (2008) Cancer statistics, 2008. CA Cancer J Clin 58: 71-96.
4. Soo KC, Tan EH, Wee J, Lim D, Tai BC, et al. (2005) Surgery and adjuvant radiotherapy vs concurrent chemoradiotherapy in stage III/IV nonmetastatic squamous cell carcinoma of the head and neck: a randomized comparison. Br J Cancer 93: 279-286.
5. Lauciello FR, Vergo T, Schaaf NG, Zimmerman R, (1980) Prosthodontic and speech rehabilitation after partial and complete glossectomy. J Prosthet Dent 43: 204-211.
6. Pauloski BR, Rademaker AW, Logemann JA, McConnell FM, Heiser MA, et al. (2004) Surgical variables affecting swallowing in patients treated for oral/oropharyngeal cancer. Head Neck 26: 625-636.
7. Kuntz AL, Weymuller EA, (1999) Impact of neck dissection on quality of life. Laryngoscope 8: 1334-1338.
8. Parsons JT, Mendenhall WM, Stringer SP, Amdur RJ, Hinerman RW, et al. (2002) Squamous cell carcinoma of the oropharynx: surgery, radiation therapy, or both. Cancer 94: 2967-2980.
9. Nguyen NP, Vos P, Smith HJ, Ly BH, Karlsson U, et al. (2007) Concurrent chemoradiation for locally advanced oropharyngeal cancer. Am J Otolaryngol 28: 3-8.
10. Nguyen NP, Frank C, Moltz CC, Vos P, Smith HJ, et al. (2009) Analysis of factors influencing aspiration risk following chemoradiation for oropharyngeal cancer. Br. J Radiol 82: 675-680.
11. de Arruda FF, Puri DR, Zhung J, Narayana A, Wolden S, et al. (2006) Intensity-modulated radiation therapy for the treatment of oropharyngeal carcinoma: The Memorial Sloan Kettering center experience. Int J Radiat Oncol Biol Phys 64: 363-373.
12. Lee TF, Fang FM, Chao PJ, Su TJ, Wang LK, et al. (2008) Dosimetric comparisons of helical tomotherapy and step-and-shoot intensity-modulated radiotherapy in nasopharyngeal carcinoma. Radiother Oncol 89: 89-96.
13. Jacob V, Bayer W, Astner ST, Kneschaurek P, (2010) A planning comparison of dynamic IMRT for different collimator leaf thickness with helical tomotherapy and RapidArc for prostate and head and neck tumors. Strahlenther Onkol 186: 502-510.
14. Murthy V, Master Z, Gupta T, Ghosh-Laskar S, Buddrukkar A, et al. (2010) Helical tomotherapy for head and neck squamous cell carcinoma: Dosimetric comparison with linear accelerator-based step-and-shoot IMRT. J Cancer Res Treat 6: 194-198.
15. Chen AM, Lee NY, Yang CC, Liu T, Naravan S, et al. (2010) Comparison of intensity-modulated radiotherapy using helical tomotherapy and segmental multileaf collimator-based techniques for nasopharyngeal carcinoma: dosimetric analysis incorporating quality assurance guidelines from RTOG 0225. Technol Cancer Res Treat 9: 291-298.
16. Nguyen NP, Ceizyk M, Vos P, Vinh-Hung V, Davis R, et al. (2010) Effectiveness of image-guided radiotherapy for laryngeal sparing in head and neck cancer. Oral Oncol 46: 283-286.
17. Ulrich S, Sterzing F, Nill S, Schubert K, Herfarth KK, et al. (2009) Comparison of arc-modulated cone beam therapy and helical tomotherapy for three different types of cancer. Med Phys 36: 4702-4710.
18. Nguyen NP, Smith-Raymond L, Vinh-Hung V, Sloan D, Davis R, et al. (2011) Feasibility of Tomotherapy to save the cochlea from excessive radiation in head and neck cancer. Oral Oncol 47: 414-419.
19. Cannon DM, Lee NY, (2008) Recurrence in region of spared parotid gland afterdefinitive intensity-modulated radiotherapy for head and neck cancer. Int J Radiat Oncol Biol Phys 70: 660-665.
20. Salaun PY, Abgral R, Querellou S, Couturier O, Valette G, et al. (2007) Does 18-fluorodeoxyglucose positron emission tomography improve recurrence detection in patients treated for head and neck squamous cell carcinoma with negative clinical follow-up? Head Neck 29: 1125-1130.
21. Malone JP, Gerberi MAT, Vasireddy S, Hughes LF, Rao K, et al. (2009) Early prediction of response to chemoradiotherapy for head and neck cancer. Arch Otolaryngol Head Neck Surg 135: 1119-1125.
22. Yao M, Smith RB, Graham MM, Hoffman HT, Tan H, et al. (2005) The role of FDG PET in management of neck metastases from head and neck cancer after definitive radiotherapy treatment. Int J Radiat Oncol Biol Phys 63: 991-999.
23. Ong SC, Schoder H, Lee NY, Patel SG, Carlson D, et al. (2008) Clinical utility of 18F-FDG PET/CT in assessing the neck after concurrent chemoradiotherapy for locoregionally advanced head and neck cancer. J Nucl Med 49: 532-540.
24. Daly ME, Le QT, Maxim PG, Loo BW, Kaplan MJ, et al. (2010) Intensity-modulated radiotherapy in the treatment of oropharyngeal cancer: clinical outcomes and pattern of failure. Int J Radiat Oncol Biol Phys 76: 1339-1346.
25. Feng FY, Kim HM, Lyden TH, Haxer MJ, Worden FP, et al. (2010) Intensity-modulated chemoradiotherapy aiming to reduce dysphagia in patients with oropharyngeal cancer: clinical and functional results. J Clin Oncol 28: 2732-2738.
26. Buntzel J, Glatzel M, Mucke R, Micke O, Bruns F, (2007) Influence of amifostine on late radiation-toxicity in head and neck cancer-a follow-up study. Anticancer Res 27: 1953-1956.
27. Buntzel J, Kuttner K, Frolich D, Glatzel M, (1998) Selective cytoprotection withamifostine in concurrent radiochemotherapy for head and neck cancer. Ann Oncol 9: 505-509.